Form 8-K - Current report:
SEC Accession No. 0001437749-20-025883
Filing Date
2020-12-23
Accepted
2020-12-23 16:41:11
Documents
6
Period of Report
2020-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20201223_8k.htm 8-K 28555
2 EXHIBIT 1.1 ex_218854.htm EX-1.1 52405
3 EXHIBIT 5.1 ex_218855.htm EX-5.1 17725
4 EXHIBIT 10.1 ex_218856.htm EX-10.1 203904
5 EXHIBIT 99.1 ex_218858.htm EX-99.1 9148
6 img.jpg GRAPHIC 3302
  Complete submission text file 0001437749-20-025883.txt   317564
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 201412863
SIC: 2834 Pharmaceutical Preparations